Barrio M Isabel, Martínez M Carmen, Prados Concepción, Girón Rosa M, Maiz Luis, Martínez M Teresa
Sección de Neumología Pediátrica, Hospital Universitario La Paz, Madrid, Spain.
Arch Bronconeumol. 2008 Feb;44(2):109-12. doi: 10.1016/s1579-2129(08)60021-x.
The isolation of Nocardia species from the respiratory secretions of patients with cystic fibrosis presents problems with important clinical implications. From the sputum culture of a total of 387 patients with cystic fibrosis, Nocardia species was isolated in 9 cases (2%; 8 females and 1 male) with a mean (SD) age of 17 (7) years. Sixty-seven percent of the patients were asymptomatic and no relevant radiographic or analytical changes were detected. In only 3 patients was of Nocardia species isolated again in successive samples. Two patients were not treated, 7 were treated with cotrimoxazole and 3 with minocycline; in 2 cases therapy was intravenous. After a mean follow-up of 48 (33) months, all patients had improved. Isolation of Nocardia species from the secretions of patients with cystic fibrosis does not necessarily imply infection and the need for treatment should be assessed on an individual basis.
从囊性纤维化患者的呼吸道分泌物中分离出诺卡菌属会带来一些具有重要临床意义的问题。在总共387例囊性纤维化患者的痰培养中,9例(2%;8名女性和1名男性)分离出诺卡菌属,平均(标准差)年龄为17(7)岁。67%的患者无症状,未检测到相关的影像学或分析变化。仅3例患者在连续样本中再次分离出诺卡菌属。2例患者未接受治疗,7例接受复方新诺明治疗,3例接受米诺环素治疗;2例采用静脉治疗。平均随访48(33)个月后,所有患者病情均有改善。从囊性纤维化患者的分泌物中分离出诺卡菌属不一定意味着感染,应根据个体情况评估是否需要治疗。